Skip to main content

Prevalence and associated factors of schistosomiasis among pregnant women in northern Senegal



Schistosomiasis remains a public health concern worldwide. It is responsible for more than 240 million cases in 78 countries, 40 million of whom are women of childbearing age. In the Senegal River basin, both Schistosoma haematobium and Schistosoma mansoni are very prevalent in school-age children. However, there is a lack of information on the burden of schistosomiasis in pregnant women, which can cause complications in the pregnancy outcome. This study aimed to determine the prevalence and associated factors of schistosomiasis in pregnant women.


We conducted a prospective cross-sectional study of pregnant women attending antenatal clinics at the health center of the Senegalese Sugar Company and at the hospital of Richard Toll between August and December 2021. The urine and stool samples collected were examined using microscopy techniques and quantitative polymerase chain reaction (qPCR) to detect the presence of S. haematobium and S. mansoni. The urines were previously tested using urine reagent strips to detect hematuria and proteinuria. Socio-demographical, clinical, and diagnostically data were recorded by the midwife and the gynaecologist. The data were analyzed using a logistic regression model.


Among the 298 women examined for the infection by microscopic, 65 (21.81%) were infected with urogenital schistosomiasis, 10 (3.36%) with intestinal schistosomiasis, and 4 (1.34%) were co-infected with both types of schistosomiasis. Out of the 288 samples tested by qPCR, 146 (48.99%) were positive for S. haematobium, 49 (35.51%) for S. mansoni and 22 (15.94%) for both species (co-infection). Pregnant women having microscopic haematuria and proteinuria were significantly more infected (p < 0.05).


This study has revealed a high prevalence of schistosomiasis in pregnant women in Senegal. The qPCR allowed us to detect more cases compared to the microscopy. There is a need to conduct more studies to understand the real burden of the disease and to set up a surveillance system to prevent pregnancy-related complications.

Peer Review reports


Schistosomiasis is a group of chronic tropical diseases caused by parasitic worms of the genus Schistosoma [1]. Schistosoma haematobium and Schistosoma mansoni causing respectively urogenital and intestinal schistosomiasis, are the most prevalent in sub-Saharan Africa [2]. Transmission of schistosomiasis has been reported in 91 countries worldwide [3] and it is the second most endemic parasitic disease in the world after malaria [4]. In 2021, schistosomiasis preventive chemotherapy was required in 51 countries, for a total of 251.4 million people including 136 million School age children and 115.4 million adults [3]. Mortality due to the disease and the number of persons at risk were respectively estimated at 200,000 and 700 million [5]. The school age children are the most affected group due to their frequent contact with the water infested by Schistosoma larvae excreted by snail intermediate hosts belonging to the genus Bulinus and Biomphalaria [6, 7]. Females, in particular, are more likely to be exposed to the infection because of frequent domestic activities carried out in infested water [8, 9] such as washing clothes, fetching water, and bathing in addition to drinking and laundry [9].

It is estimated that over 40 million of women of reproductive age are affected by schistosomiasis worldwide, with approximately 10 million infected per year during pregnancy in Africa [10]. These data are mostly based on results of standard microscopy [11,12,13] and few studies used molecular or immunological techniques [14,15,16] to detect Schistosoma infection in urine or stool samples.

Schistosomiasis control targets implemented by national control programs, focus exclusively on preventive chemotherapy on school-aged children using Praziquantel (PZQ), the only anthelmintic available and effective against schistosomiasis [17]. Therefore, despite the high burden of schistosomiasis during pregnancy, women of reproductive age are not systematically included in mass treatment campaigns, even though studies have demonstrated the safety of PZQ for pregnant women [18, 19] and the recommendation of the World Health Organization (WHO) to include pregnant women in Mass Drug Administration [18].

Studies in other countries have reported significant association of schistosomiasis and adverse pregnancy outcomes parameters (miscarriage, stillbirth, preterm, and small-for-gestational age) and also other clinical parameters (low birth weight delivery, neonatal death, or length for age Z scores) [20, 21].

In northern Senegal, particularly in the Senegal River basin, the rapid evolution of the epidemiological system has led to an explosion of schistosomiasis, with S. mansoni and S. haematobium becoming co-endemic [22, 23]. The presence of irrigation canals, the proximity and regular frequentation of water points are often cited as the main risk factors for school-age children and adults [8]. However, few data are available about the factors associated with the contamination of pregnant women in this part of Senegal. Thus, this study assessed the prevalence and intensity of the schistosomiasis infection and the associated factors in pregnant women attending antenatal care in the District of Richard Toll in northern Senegal.


Study area

This study was carried out in two health facilities: a private health center named Senegalese Sugar Company health center (CSS) and a public health center named Secondary Public Health Establishment (EPS) both located in the district of Richard Toll (16°27′44″ North and 15°42′02″ West) at 108 km from the Saint-Louis region in northern Senegal (Fig. 1). Population increased from 48,968 in 2007 to 60,127 in 2014 [24]. . The climate is tropical with a short rainy season and long dry season [25]. Average annual precipitations were about 215 mm and temperatures varied between 30 °C and 39 °C [25].

Intestinal and urogenital schistosomiasis were endemic in the district a few years after the construction of the Diama dam in 1986 [24]. The area is mainly characterized by the Taouey canal linking the Senegal River to the Lake of Guiers and several secondary irrigation canals for agricultural activities [26]. Although many households have access to tap water, most of the activities implicating water are done by the population on the banks of the river, Taouey and secondary canals for domestic and recreational activities [27].

Fig. 1
figure 1

Location of the study sites and the two health facilities

Study design and period

We carried out a prospective cross-sectional study during five months from August 2021 to December 2021 in the CCS and EPS health facilities. The study was done in collaboration with midwife and gynecologist of each facility. All pregnant women who come for the first time at the health facility and those who were in their first, second, and third trimester antenatal care were enrolled based on the consultation register at the two health facilities.

Study population and participant selection

The study population consisted of pregnant women aged between 14 and 43 years attending antenatal care at the CSS and EPS health facilities. Participants were selected based on the daily register of consultation used by the midwife during the four months of study recruitment. After identification based in the name of participant in the register, the study was explained to each woman before asking to sign consent to participate in the study.

Collection of sociodemographic, clinical and paraclinical data

After consent signature, a validated questionnaire designed one android tablet using the Open Data Kit (ODK) platform was administered to each participant. The health worker responsible for the welcoming of patients registered the information on identity and age. The study team collected the other demographic and socio-economic information (locality, marital status, educational level and economical activities), source of water (lake, canal, river, basin water, and backwater) and woman behavior in relation to the water bodies (drinking, laundry, bathing, household water source and other use). The other information related to schistosomiasis infection and treatment history with PZQ, clinical parameters (history of haematuria and schistosomiasis infection, type of treatment or drug administered within the last 6 months), the possession of a health booklet were also collected during sampling. The other clinical data were collected by the gynecologist. Parity and birth weight were recorded in the health booklet and women were telephoned after childbirth to obtain pregnancy outcome and birth weight.

Sample collection

Each participant interviewed received two pre-labeled sterile containers of 60 ml for urine, stool with the identification number, and asked to give urine and stool samples as soon as possible between 10:00 am and 2:00 pm corresponding to the health facilities consultation time. Before giving the container, each participant was briefed on the importance of sample collection at this time and then asked when possible, to give the totality of urine.

Macroscopic and microscopic examination of urine and stool samples

Urine examination

The first step was the macroscopic observation followed by the screening of the haematuria, proteinuria, presence of nitrites and leucocytes in urine sample using reagent strips for urinalysis (Siemens Healthcare Diagnostics Inc. Tarrytown, NY 10,591 − 5097 USA). In a second step, S. haematobium eggs were searched in urine using the filtration method described by Plouvier et al. [28]. Briefly, each urine sample was gently shaken to ensure homogenization of the eggs before filtering 10 ml of the liquid through a Swinnex® filter. Filters were observed under a microscope after deposited a drop of lugol’s iodine in order to visualize the eggs. The number of S. haematobium eggs per 10 ml of urine (infection intensity) was recorded. The infection intensity after microscopic examination for S. haematobium was classified as light (1–49 eggs/10 ml of urine) or heavy (≥ 50 eggs/10 ml of urine) [29].

Stool examination

S. mansoni eggs were screened in stool samples using the Kato-Katz technique as described in the WHO guideline [30]. Two Kato-Katz thick smears of 41.7 mg of stool were prepared and read 24 h later under a microscope. As it is difficult to shake the stools to homogenize them like the urine sample, we took 41.7 mg in two different corners of the stool to increase the chances of detecting eggs. For S. mansoni, the number of eggs per gram of faeces (epg) was calculated by multiplying the mean egg count of the two slides by 24. The infection intensity was classified as light (1–99 epg), moderate (100–399 epg) and high (≥ 400 epg) [31]. For each urine and stool sample, one aliquot was prepared in 1.5 ml Eppendorf tube and conserved at -20 °C in order to confirm the diagnostic by molecular biology.

Molecular diagnostic

DNA extraction in urine and stool

For both urine and stool, the DNA extraction was done by the same extraction kit. A 200 µl volume of urine and a mince up to 30 mg of stool were centrifuged separately in a 1.5 ml Eppendorf tube. DNA was extracted from the pellet using the EZNA® Tissue DNA Kit (Omega Bio-tek, USA) following the manufacture recommendations. The extracts DNA were stored at -20 °C until use.

DNA detection and quantification by polymerase chain reaction (qPCR)

The S. haematobium Dra1 gene previously described by Hamburger et al. [32] was targeted by qPCR technique. Primers and probes sequences used were Sh-RV: 5′-TCA-CAA-CGA-TAC-GAC-CAA-C-3′; Sh-FW: 5′-GAT-CTC-ACC-TAT-CAG-ACG-AAA-C-3′; Sh-probe: 5’-FAM-TGT-TGG-TGG-AAG-TGC-CTG-TTT-CGC-AA-TAMRA-3’. Dra1 qPCR was performed with a 20 µl reaction mix containing 5 µl of DNA, 3.5 µl of sterile ultrapure water, 0.5 µl of each primer, 0.5 µl of TaqManTM probe (Applied Bio-systems, Foster City, CA, USA), and 10 µl of the ROCHE® Master mix Master Mix. The DNA amplification was performed on a CFX96 thermal cycler (Bio-Rad). The thermocycler program consisted by an initial denaturation and purification step of 5 min at 95 °C followed by denaturation step of 39 cycles of 30 s at 95 °C, and a hybridization step of 60 s at 60 °C. DNA quantification was expressed on the basis of cycle threshold (Ct) value. At each assay, a negative control and a positive S. haematobium group control between 18 and 23 Ct value were used. Any sample with a Ct < 35 was considered as positive. DNA from S. haematobium adult worm of the VITROME lab of Dakar was used as positive control for S. haematobium.

S. mansoni DNA was detected by qPCR, targeting a highly repeated 121-bp sequence of S. mansoni (Sm1-7) described by Wichmann et al. [33]. Primers sequences used were: SRA1: 5’-CCACGCTCTCGCAAATAATCT-3’ and SRS2: 5’-CAACCGTTCTATGAAAATCGTTGT-3. The probes sequences were SRP: 5’-FAMTCCGAAACCACTGGACGGATTTTTATGAT-TAMRA-3’ [34]. The qPCR was performed with a 20 µl reaction mixture containing 5 µl of DNA, 3.5 µl of sterile ultrapure water, 0.5 µl of each primer, 0.5 µl of TaqManTM probe and 10 µl of Master Mix. Positive control for S. mansoni was obtained from the VITROME lab at the Aix-Marseille University. The reaction was performed on a CFX96 thermal cycler (BIO-RAD), with the program consisting of an initial purification step of 2 min at 50 °C followed by denaturation for 10 min at 95 °C, hybridization for 40 cycles at 95 °C for 15 s, and 60 °C for 1 mn sampling maintained at 4˚C. DNA detection was expressed as the cycle threshold (Ct) value. At each assay, a negative and a positive S. mansoni control (18 < Ct < 23) were used. Any sample with a Ct < 35 was considered positive.

Statistical analysis

For both urine and stool examination, a participant was considered as positive if she had microscopic and/or qPCR positive. Statistical analysis was done using Stata software version 14.0 (College Station, Texas, USA). The comparison of the sensitivity and specificity of the techniques was calculated considering PCR as reference method. The sensitivity was calculated as the positive samples from microscopy divided by the total positive samples from PCR and the specificity as the negative samples issued from microscopy divided by the total negative obtained from the PCR method. In order to search for any statistically significant association between schistosomiasis and the parameters studied, we carried out “logistic regression bivariate analyses”. Variables with a p-value < 0.2 in bivariate analyses were integrated in multivariate analyses. Multivariate analyses were performed using a logistic regression model. Step-wise elimination of variables was performed based on the variables with high p-value and AIC (Akaike information criterion) in the final model. The significance level was fixed at p-value = 0.05 in the final model.


Characteristics of the study population

A total of 298 pregnant women living in Richard Toll and surrounding villages took part in the study. The total number of pregnant women who attended the antenatal clinic at the EPS was 232 (77.85%) and 66 (22.15%) at the CSS. Majority of the participants were married 286 (95.97%) and were aged from 20 to 35 years 213 (71.48%). They were divided into three age groups: 14 to 19 years 55 (18.46%), between 20 and 35 years 213 (71.48%) and > 35 years 30 (10.07%). The majority of women were illiterate 159 (53.36%). The frequencies of education levels were primary school 53 (17.79%), secondary school 59 (19.80%) and high school, 27 (9.06%). Most of the women had no income-generating activity (79.19%). The other characteristics of this study, i.e. women’s attitudes to water and clinical and diagnostical parameters, are detailed in Table 1.

Table 1 Descriptive analysis of all parameters collected among pregnant women in Richard Toll

Prevalence and intensity of schistosoma infection according to the different techniques

Urine filtration technique

Out of the 298 urine samples from pregnant women analyzed by urine filtration method, a total of 65 (21.81%) were positive to urogenital schistosomiasis. The intensity of infection was low with 87.7% excreting less than 49 eggs/10 ml of urine. The maximum egg load was 200 eggs/10 ml of urine.

Kato Katz technique

A total of 142 stool samples were recorded among the 298 participants. Among them, 10 (7.04%) were positive for S. mansoni by the Kato-Katz technique with low intensity of infection as all women excreting less than 8 eggs/gram. Only 4 (2.82%) pregnant women were co-infected with S. haematobium and S. mansoni (Table 2).

Table 2 Prevalence of Schistosoma species according to microscopic and qPCR technique

QPCR technique

The qPCR detected 81 and 38 cases missed respectively by the urine filtration (UF) and Kato-Katz (KK) techniques. Molecular prevalence was high for S. haematobium (n = 146; 48.99%) and S. mansoni (n = 49; 35.51%), as well as for co-infection (n = 22; 15.94%) (Table 2). The results on sensitivity and specificity of each technique in the detection of S. haematobium and S. mansoni in pregnant women are summarized (Table 3).

Table 3 Sensitivity and specificity of quantitative real-time PCR (qPCR) compared to microscopy methods for the diagnostic of schistosomiasis

Bivariate analysis

Socio-demographic factors associated with schistosomiasis

Table 4 shows the bivariate analysis between Schistosoma infection detected by microscopic and molecular methods, and socio-demographic factors and history of infection. The results revealed a significant association of S. haematobium infection with the age group of pregnant women. Women aged between 20 and 35 years and those aged over 35 years were significantly protected against S. haematobium infection compared to those aged 14 to 19 years (odds ratio [OR] 0.47; 95% confidence interval (95%CI) 0.25–0.88; p = 0.019 and OR 0.32; 95%CI 0.15–0.93; p = 0.034 for 20–35 and over 35 years old, respectively).

Table 4 Logistic regression bivariate analysis exploring factors associated with schistosomiasis cases among pregnant women (n = 298) in Richard Toll (Northern Senegal)

The prevalence of S. haematobium was significantly higher in women who had undergone their antenatal care in the Richard Toll EPS than in those who had consulted the CSS (p < 0.001). Other socio-demographic factors were not significantly associated with S. haematobium infection. This was the case for married women, (OR 0.35; 95%CI 0.09–1.31; p = 0.119) primary school (OR 0.67; 95%CI 0.36–1.25; p = 0.204) secondary school (OR 0.59; 95%CI 0.32–1.08; p = 0.085), higher level (OR 0.69 ;95%CI 0.31–1.37; p = 0.381) and women with an income-generating activity (OR 1.25; 95%CI 0.71–2.20; p = 0.432). Additionally, intestinal schistosomiasis was not associated with any of the socio-demographic parameters included in this analysis (Table 4).

Clinical and diagnostical factors associated with schistosomiasis

Bivariate analysis showed that medium (OR 5.41; 95%CI 1.75–16.79; p = 0.003), intense (OR 3.18; 95%CI 1.33–7.64; p = 0.009) and very intense (OR 4.46; 95%CI 1.41–14.12; p = 0.011) blood; low (OR 1.95; 95%CI 1.04–3.68; p = 0.038), medium (OR 2.32; 95%CI 1.22–4.43; p = 0.011) intense (OR 6.42; 95%CI 2.11–19.56; p = 0.001) proteinuria and low (OR 2.20 ; 95%CI 1.17–4.13; p = 0.014) and intense (OR 2.09 ; 95%CI 1.16–3.77; p = 0.015) leukocyte detected by reagent trips in pregnant women urine were more likely associated with increased S. haematobium infection. The presence of nitrites and glucose on strips is not associated with S. haematobium infection. The women declaring an Intermittent Preventive Treatment with sulfadoxine-pyrimetamine (IPT) within the last 6 months and those with anemia were protected against intestinal schistosomiasis infection (OR 0.46; 95%CI 0.22–0.99; p = 0.048; OR 0.38; 95%CI 0.15–0.99; p = 0.047 respectively), while those with very intense blood in urine had a significant risk of having the intestinal infection (OR 5.15; 95%CI 1.23–21.66; p = 0.049) (Table 4). When considering all cases of schistosomiasis, only medium, intense, and very intense blood in urine and low, medium, and intense proteinuria were significantly associated with having schistosomiasis infection (p < 0.05) (Table 4).

Multivariate analysis

Multivariate analysis by logistic regression confirmed that the prevalence of S. haematobium was 4.13-fold higher in the EPS of Richard Toll than in the CSS (adjusted odds ratio [aOR] 4.13; 95% confidence interval (95%CI) 2.10–8.09; p < 0.001). Association with factors such as the presence of blood on strips (aOR 7.02 ; 95%CI 2.06–23.88; p = 0.002; aOR 3.52 ; 95%CI 1.38–8.96; p = 0.008; aOR 3.96 ; 95%CI 1.08–14.56; p = 0.038; for medium, intense and very intense blood on strip respectively) and the presence of protein (aOR 2.02 ; 95%CI 1.02–4.01; p = 0.045; aOR 2.16 ; 95%CI 1.06–4.42; p = 0.035; aOR 4.16 ; 95%CI 1.23–14.12; p = 0.022; for low, medium and intense respectively) with S. haematobium infection was confirmed. With a p = 0.05, the pregnant women aged 20–35 years were likely protected against the S. haematobium infection compared with those aged 14 to 19 years. For S. mansoni, only the presence of blood on strips at a very high intensity remained significantly associated with the infection (aOR 5.23; 95%CI 1.01–27.10; p = 0.049). Considering all type of Schistosoma infection, significant associations were only confirmed with medium (aOR 3.56; 95%CI 1.12–11.33; p = 0.031) and intense (aOR 2.78; 95%CI 1.04–7.42; p = 0.041) presence of blood on strips and for all the categories of proteinuria: low (aOR 2.16; 95%CI 1.13–4.14; p = 0.02), medium (aOR 2.06; 95%CI 1.05–4.05; p = 0.036) and intense (aOR 9.14 ; 95%CI 1.89–44.21; p = 0.006) (Table 5).

Table 5 Logistic regression multivariate analysis exploring factors associated with schistosomiasis cases among pregnant women (n = 298) in the health district of Richard Toll, in northern Senegal


This is the first study examining the prevalence of schistosomiasis in pregnant women in Senegal. Using microscopic examination, we identified a high prevalence of S. haematobium 65 (21.81%) and a low prevalence of S. mansoni 10 (7%) in the endemic district of Richard Toll. These differences in prevalence between the two schistosomiasis infections reflect the actual local epidemiological situation in the Senegal River area with S. haematobium becoming more prevalent than S. mansoni in school children [35, 36]. The opposite of what happened 15 years later after the construction of the Diama dam where S. mansoni was the most prevalent [39,40,39]. To our knowledge, the national mean prevalence of S. haematobium and S. mansoni are unclear. However, a study conducted throughout the country showed that the prevalence of S. haematobium ranges from 10% after several PZQ treatments in seasonal transmission focus in central Senegal [40], to more than 90% in the Senegal River basin and the Lake de Guiers [35]. However, when considering the district level of Richard Toll, our prevalence of urogenital schistosomiasis is lower than the recent prevalence of 30% and 54%, respectively in 2017 and 2018 in volunteer adults [35]. When considering S. mansoni, our prevalence was situated in the interval of 2–20% of the prevalence recently reported in Richard Toll [35], and was so far lower than the 79–100% reported by Webster et al. [23], before recurrent mass PZQ administration by the Senegalese health ministry. Pregnant women have long been excluded from schistosomiasis treatment in Senegal, and therefore limited data on prevalence existed before this study. In addition, in neighboring countries such as Guinea, Mauritania, and Gambia, no studies were available on the prevalence of urogenital schistosomiasis in pregnant women to our knowledge. Only one study was conducted in the neighboring country of Mali with a prevalence of 11% of S. haematobium [41], lower than that reported in the present study. When considering other countries, our prevalence was similar to that reported among Nigerian pregnant women [42], while it’s higher than previous prevalence reported in other countries such as Cameroon and Tanzania where the prevalence was less than 5% [12, 43]. The prevalence of S. haematobium reported in the present study was higher than the mean global prevalence of 13.44% during pregnancy estimated from various countries worldwide [44]. This could be explained by the high endemicity of urogenital schistosomiasis in Richard Toll due to the presence of several water contacts, and high prevalence in children and adults despite Mass drug administration of Praziquantel [35, 45] .

However, the infection rate of S. mansoni in our study was lower than the global prevalence of 12.18% [44] and confirms the patterns of intestinal decrease in the Senegal river basin which is less and less detected by microscopic examination [35]. This was not the case in other countries such as Sudan [46] and Tanzania with the second having the highest prevalence of 63.5% in pregnant women [13] probably due to the difference in the sensitivity of the PCR kit used. For both S. haematobium and S. mansoni, the higher rates of low-intensity of infection are in line with what was often reported in previous studies in pregnant women in several countries [13, 21, 48,49,50,51,50].

This variation in the prevalence in pregnant women reflects the epidemiological character of schistosomiasis which changes strongly across the countries and even in the same country [53,54,55,54] but will also depend on the diagnostic method used. Today, with the availability of genetic markers, molecular diagnosis is often used to increase the possibility of parasite detection by targeting specific DNA fragments.

The majority of molecular diagnostics of Schistosomiasis in pregnant women was generally Blood-PCR-Based and always showed higher prevalence than microscopic techniques with a rate often more than 40% [15]. Our results demonstrated high prevalence by urine and stool based on qPCR for both S. haematobium and S. mansoni, respectively compared to microscopic diagnostics. Compared to microscopy, PCRs significantly increased the sensitivity of diagnosis for the detection of S. haematobium and S. mansoni in pregnant women. This ultra-sensitivity of qPCR compared to the standard techniques demonstrates its robustness and its performance in comparison with microscopy for the assessment of schistosomiasis prevalence, especially in the case of low prevalence and light egg load, but, also in the prediction of female genital schistosomiasis [55]. Quite large numbers of false negatives at microscopy evaluated by the qPCR were certainly due to errors of the microscopic operator rather than storage conditions as the sample was processed the same day of collection. A double microscopy examination of the negative sample would allow having a higher microscopy and permit these women who were considered negative to benefit from treatment.

Bivariate analysis showed that S. haematobium infection was associated with a younger age group. This can be explained by the fact that most women are young and married and in the area of Richard Toll the young mothers (daughters-in-law) are responsible for household domestic activities such as laundry and dishes, which brings them to more frequently in contact with canal and river water. It’s known that the prevalence and intensity of schistosomiasis decreases with increasing age [56]. In addition, there is evidence that immunity to S. haematobium infection depends on age and therefore affects the prevalence and quantity of eggs in infected individuals [57, 58]. Our results are in accordance with the previous study in the Richard toll area which found a higher overall prevalence of 95% in 2018 in the young participants aged 5–17 years compared to adult patients (54%), aged 18–75 years [35]. Similar results were also observed in Mali, where 11% of pregnant women infected with S. haematobium were aged between 20 and 29 [41], and also in Nigeria where a higher prevalence of 31.5% % was reported in pregnant women aged 20–24 years [42].

When considering demographic variables, our results show that women attending in the EPS of Richard Toll were significantly more infected than those attending antenatal at the CSS health center. The two structures are located on either side of the Taouey Canal, where women carry out their domestic activities. Although the EPS is closer to the Senegal River, we did not find any significant difference between the women consulting in the two health facilities with respect to the use of water sources. The difference can be attributed to the fact that the EPS is a public establishment that serves pregnant women from various localities in Richard Toll who may not have health insurance. Therefore, they may not receive systematic treatment for schistosomiasis. However, the CSS health center is a private structure that was built by the company for their employees. CSS workers and their families receive systematic treatment for schistosomiasis before and after each agricultural season by the company. Thus, these women were more likely to have a history of treatment of schistosomiasis by PZQ, resulting in a difference in prevalence between the two health facilities. However, more information on the origin of women, the level of access to safe water, and also the length of time in the area, would have allowed a better comprehension of the differences in the prevalence between the two health facilities.

There is no significant difference in the prevalence of schistosomiasis in this study between the levels of education. These results are not in line with the study by Tonga et al. [10] who report that women with higher education levels have more knowledge about the risks of the disease and therefore reduce their contact with infested water making them less infected than the other categories.

The present study showed a significant association between schistosomiasis and income-generating activity. Indeed, unemployed people have more time to do housework than employed people; so, they are for a long time into contact with water and they are more exposed to sources of infection. It was demonstrated that the professional activities in the endemic area were an indicator of the nature and intensity of contact with infested water [59]. This fact has been also reported in the two villages of Itapinassu and São Joaquin in the county of Tracunhaém (state of Pernambuco) in Brazil [60]. None other demographic factors analyzed were associated with S. mansoni compared to other studies which showed a significant association between intestinal schistosomiasis and age [12] or level of education [61].

Regarding diagnostical and clinical parameters, women who were not declared previous praziquantel treatment in the last six months were less infected with schistosomiasis than those reporting a history of schistosomiasis treatment. We assume that the first cases of women come from no endemic area such as the capital Dakar or Saint-Louis city or other cities of the central regions and recently arrived in the endemic area of Richard Toll. As the mass drug administration of Praziquantel targeted only school children, they may have never been treated since their first infection after they arrive in the study area. In the second case, it could be assumed that these women spent more time in the area and are more likely to be in permanent contact with infested waters. Other factors such as, the difference in the transmission dynamic of the disease, the type of water access frequented [45] and the lack of access to safe water for domestic activities could explain this difference [62]. These results contrast with the study conducted by Dawaki et al. [63] in North Central Nigeria in Kano State. In this study, women with infection and treatment history were more infected than those who had never reported a history of infection.

The present study showed that proteinuria was a risk factor associated to S. haematobium and S. mansoni infection in pregnant women. In addition to hematuria, this parameter could be considered a symptom of female genital schistosomiasis [64]. This parameter could be taken into account in addition to hematuria which is the most important symptom and risk factor of female genital schistosomiasis [64]. This will allow improving the detection of urogenital schistosomiasis in pregnant women in endemic areas. Low birth weights, total hemoglobin (THB), and blood group are not associated with schistosomiasis in this study. However, previous studies have demonstrated that pregnant women with urogenital schistosomiasis have an increased risk of low birth weight delivery [20] and increased risk of anemia was associated with a high level of S. mansoni infection [13]. Other studies showed a close relationship between schistosomiasis and anemia caused by a fall in hemoglobin level [65]. The availability of data on all the parameters studied in all participants would allow us to have a greater statistical strength and to get other parameters associated with schistosomiasis.


The presented study has revealed a high prevalence of urogenital schistosomiasis in pregnant women at Richard Toll in Senegal. Pregnant women who attended the public health facility of EPS were more infected than those attending the private health facility of the Senegalese Sugar Company. Molecular diagnostics by qPCR were more sensitive than the urine filtration and Kato-Katz techniques. More studies are needed to assess the real burden of schistosomiasis in pregnant women and the outcome of pregnancy. Moreover, implementing schistosomiasis surveillance even on the basis of haematuria and or proteinuria during antenatal care consultations to treat women to prevent pregnancy-related complications.

Data availability

The datasets used in this study are available upon reasonable request from the corresponding author.


  1. McManus DP, Dunne DW, Sacko M, Utzinger J, Vennervald BJ. Zhou X-N. Schistosomiasis. Nat Rev Dis Primer. 2018;4:13.

    Article  Google Scholar 

  2. Hailegebriel T, Nibret E, Munshea A. Prevalence of Schistosoma mansoni and S. haematobium in Snail Intermediate Hosts in Africa: a systematic review and Meta-analysis. J Trop Med. 2020;2020:8850840.

    Article  PubMed  PubMed Central  Google Scholar 

  3. WER9748-eng-fre.pdf.

  4. Mohamed I, Kinung’hi S, Mwinzi PNM, Onkanga IO, Andiego K, Muchiri G, et al. Diet and hygiene practices influence morbidity in schoolchildren living in Schistosomiasis endemic areas along Lake Victoria in Kenya and Tanzania-A cross-sectional study. PLoS Negl Trop Dis. 2018;12:e0006373.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Molehin AJ. Schistosomiasis vaccine development: update on human clinical trials. J Biomed Sci. 2020;27:28.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Elias M, Hanafi RS, El-Bardicy S, Hafez EA, El Ridi R. Resistance of Biomphalaria alexandrina to Schistosoma mansoni and Bulinus Truncatus to Schistosoma haematobium correlates with unsaturated fatty acid levels in the snail soft tissue. J Parasitol Res. 2020;2020:8852243.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Colley DG, Bustinduy AL, Secor WE, King CH. Human schistosomiasis. Lancet. 2014;383:2253–64.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Senghor B, Mathieu-Begné E, Rey O, Doucouré S, Sow D, Diop B, et al. Urogenital schistosomiasis in three different water access in the Senegal river basin: prevalence and monitoring praziquantel efficacy and re-infection levels. BMC Infect Dis. 2022;22:968.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Ntonifor HN, Ajayi JA. Water contact and Schistosoma haematobium infection. A case study of some communities in Toro local government council area (TLGCA) of Bauchi State. Niger J Nat Appl Sci. 2005;1:54–9.

    Google Scholar 

  10. Friedman JF, Mital P, Kanzaria HK, Olds GR, Kurtis JD. Schistosomiasis and pregnancy. Trends Parasitol. 2007;:159–64.

  11. Tay SCK, Nani EA, Walana W. Parasitic infections and maternal anaemia among expectant mothers in the Dangme East district of Ghana. BMC Res Notes. 2017;10:3.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Tonga C, Ngo Bayoi C, Tchanga FC, Yengue JF, Wepnje GB, Nyabeyeu Nyabeyeu H, et al. Schistosomiasis among pregnant women in Njombe-Penja health district, Cameroon. J Infect Dev Ctries. 2019;13:1150–8.

    Article  PubMed  Google Scholar 

  13. Ajanga A, Lwambo NJS, Blair L, Nyandindi U, Fenwick A, Brooker S. Schistosoma mansoni in pregnancy and associations with anaemia in northwest Tanzania. Trans R Soc Trop Med Hyg. 2006;100:59–63.

    Article  PubMed  Google Scholar 

  14. Miller K, Choudry J, Mahmoud ES, Lodh N. Accurate diagnosis of Schistosoma mansoni and S. haematobium from filtered urine samples collected in Tanzania, Africa. Pathogens. 2024;13:59.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Hoffmann T, Carsjens I, Rakotozandrindrainy R, Girmann M, Randriamampionona N, Maïga-Ascofaré O, et al. Serology- and blood-PCR-based screening for schistosomiasis in pregnant women in Madagascar—A cross-sectional study and test comparison approach. Pathogens. 2021;10:722.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Aryeetey YA, Essien-Baidoo S, Larbi IA, Ahmed K, Amoah AS, Obeng BB, et al. Molecular diagnosis of Schistosoma infections in urine samples of school children in Ghana. Am J Trop Med Hyg. 2013;88:1028–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. World Health Organization. World health statistics 2012. Stat Sanit Mond. 2012;2012:176.

    Google Scholar 

  18. Friedman JF, Olveda RM, Mirochnick MH, Bustinduy AL, Elliott AM. Praziquantel for the treatment of schistosomiasis during human pregnancy. Bull World Health Organ. 2018;96:59–65.

    Article  PubMed  Google Scholar 

  19. Olveda RM, Acosta LP, Tallo V, Baltazar PI, Lesiguez JLS, Estanislao GG, et al. Efficacy and safety of praziquantel for the treatment of human schistosomiasis during pregnancy: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2016;16:199–208.

    Article  CAS  PubMed  Google Scholar 

  20. Mombo-Ngoma G, Honkpehedji J, Basra A, Mackanga JR, Zoleko RM, Zinsou J, et al. Urogenital schistosomiasis during pregnancy is associated with low birth weight delivery: analysis of a prospective cohort of pregnant women and their offspring in Gabon. Int J Parasitol. 2017;47:69–74.

    Article  PubMed  Google Scholar 

  21. Murenjekwa W, Makasi R, Ntozini R, Chasekwa B, Mutasa K, Moulton LH, et al. Determinants of urogenital schistosomiasis among pregnant women and its association with pregnancy outcomes, neonatal deaths, and child growth. J Infect Dis. 2021;223:1433–44.

    Article  PubMed  Google Scholar 

  22. Boon NAM, Van Den Broeck F, Faye D, Volckaert FAM, Mboup S, Polman K, et al. Barcoding hybrids: heterogeneous distribution of Schistosoma haematobium × Schistosoma bovis hybrids across the Senegal River Basin. Parasitology. 2018;145:634–45.

    Article  PubMed  Google Scholar 

  23. Webster BL, Diaw OT, Seye MM, Webster JP, Rollinson D. Introgressive hybridization of Schistosoma Haematobium Group species in Senegal: Species Barrier Break Down between Ruminant and Human schistosomes. PLoS Negl Trop Dis. 2013;7:e2110.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Fall CB. Réévaluation de l’épidémiologie des bilharzioses dans la commune de Richard Toll. 2015.

  25. Sène M. La gestion urbaine à l’épreuve de la décentralisation à Richard-Toll: des structures perfectibles à un développement local limité | European Scientific Journal, ESJ. 2020. Accessed 10 Mar 2024.

  26. Cogels F, Frabouiet-Jussiia S, Olli V. Multipurpose use and water quality challenges in Lac De Guiers (Senegal). Water Sci Technol J Int Assoc Water Pollut Res. 2001;44:35–46.

    Article  CAS  Google Scholar 

  27. Sow S, de Vlas SJ, Stelma F, Vereecken K, Gryseels B, Polman K. The contribution of water contact behavior to the high Schistosoma mansoni infection rates observed in the Senegal River Basin. BMC Infect Dis. 2011;11:198.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Plouvier S, Leroy J, Colette J. A propos d’une technique simple de filtration des urines dans le diagnostic de la bilharziose urinaire en enquête de masse. Med Trop. 1975;35:229–30.

    Google Scholar 

  29. WHO. Lutte contre la schistosomiase: rapport d’un Comité OMS d’experts [réuni à Genève du 8 au 13 novembre 1984]. 1984. Accessed 20 Mar 2024.

  30. World Health Organization. Bench aids for the diagnosis of intestinal parasites. 2nd ed. Geneva: World Health Organization; 2019.

    Google Scholar 

  31. Allen HE, Crompton DWT, de Silva N, LoVerde PT, Olds GR. New policies for using anthelmintics in high risk groups. Trends Parasitol. 2002;18:381–2.

    Article  PubMed  Google Scholar 

  32. Hamburger J, He-Na null, Abbasi I, Ramzy RM, Jourdane J, Ruppel A. Polymerase chain reaction assay based on a highly repeated sequence of Schistosoma haematobium: a potential tool for monitoring schistosome-infested water. Am J Trop Med Hyg. 2001;65:907–11.

    Article  CAS  PubMed  Google Scholar 

  33. Wichmann D, Panning M, Quack T, Kramme S, Burchard G-D, Grevelding C, et al. Diagnosing schistosomiasis by detection of cell-free parasite DNA in human plasma. PLoS Negl Trop Dis. 2009;3:e422.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Cnops L, Soentjens P, Clerinx J, Van Esbroeck M. A Schistosoma haematobium-specific real-time PCR for diagnosis of urogenital schistosomiasis in serum samples of international travelers and migrants. PLoS Negl Trop Dis. 2013;7:e2413.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Léger E, Borlase A, Fall CB, Diouf ND, Diop SD, Yasenev L, et al. Prevalence and distribution of schistosomiasis in human, livestock, and snail populations in northern Senegal: a one health epidemiological study of a multi-host system. Lancet Planet Health. 2020;4:e330–42.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Catalano S, Léger E, Fall CB, Borlase A, Diop SD, Berger D, et al. Multihost Transmission of Schistosoma mansoni in Senegal, 2015–2018. Emerg Infect Dis. 2020;26:1234–42.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Shaw DJ, Vercruysse J, Picquet M, Sambou B, Ly A. The effect of different treatment regimens on the epidemiology of seasonally transmitted Schistosoma haematobium infections in four villages in the Senegal River Basin, Senegal. Trans R Soc Trop Med Hyg. 1999;93:142–50.

    Article  CAS  PubMed  Google Scholar 

  38. Talla I, Kongs A, Verlé P, Belot J, Sarr S, Coll AM. Outbreak of intestinal schistosomiasis in the Senegal River Basin. Ann Soc Belg Med Trop. 1990;70:173–80.

    CAS  PubMed  Google Scholar 

  39. Talla I, Kongs A, Verlé P. Preliminary study of the prevalence of human schistosomiasis in Richard-Toll (the Senegal river basin). Trans R Soc Trop Med Hyg. 1992;86:182.

    Article  CAS  PubMed  Google Scholar 

  40. Senghor B, Diaw OT, Doucoure S, Seye M, Diallo A, Talla I, et al. Impact of Annual Praziquantel treatment on urogenital schistosomiasis in a seasonal transmission focus in central Senegal. PLoS Negl Trop Dis. 2016;10:e0004557.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Ayoya MA, Spiekermann-Brouwer GM, Traoré AK, Stoltzfus RJ, Garza C. Determinants of anemia among pregnant women in Mali. Food Nutr Bull. 2006;27:3–11.

    Article  PubMed  Google Scholar 

  42. Salawu OT, Odaibo AB. Schistosomiasis among pregnant women in rural communities in Nigeria. Int J Gynecol Obstet. 2013;122:1–4.

    Article  Google Scholar 

  43. Siegrist D, Siegrist-Obimpeh P. Schistosoma haematobium infection in pregnancy. Acta Trop. 1992;50:317–21.

    Article  CAS  PubMed  Google Scholar 

  44. Cando LFT, Perias GAS, Tantengco OAG, Dispo MD, Ceriales JA, Girasol MJG et al. The global prevalence of Schistosoma mansoni, S. japonicum, and S. haematobium in pregnant women: A systematic review and meta-analysis. Trop Med Infect Dis. 2022;7:354.

  45. Senghor B, Mathieu-Begné E, Rey O, Doucouré S, Sow D, Diop B et al. Urinary schistosomiasis in three different water-access in the Senegal River Basin: monitoring praziquantel efficacy and re-infection levels. Preprint. In Review; 2022.

  46. Khalid A, Abdelgadir MA, Ashmaig A, Ibrahim AM, Ahmed A-AM, Adam I. Schistosoma mansoni infection among prenatal attendees at a secondary-care hospital in central Sudan. Int J Gynecol Obstet. 2012;116:10–2.

    Article  Google Scholar 

  47. Wepnje GB, Anchang-Kimbi JK, Ndassi VD, Lehman LG, Kimbi HK. Schistosoma haematobium infection status and its associated risk factors among pregnant women in Munyenge, South West Region, Cameroon following scale-up of communal piped water sources from 2014 to 2017: a cross-sectional study. BMC Public Health. 2019;19:392.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Anchang-Kimbi JK, Elad DM, Sotoing GT, Achidi EA. Coinfection with Schistosoma haematobium and Plasmodium falciparum and anaemia severity among pregnant women in Munyenge, Mount Cameroon area: a cross-sectional study. J Parasitol Res. 2017;2017:6173465.

    Article  PubMed  PubMed Central  Google Scholar 

  49. McClure EM, Meshnick SR, Mungai P, Malhotra I, King CL, Goldenberg RL, et al. The association of parasitic infections in pregnancy and maternal and fetal anemia: a cohort study in coastal Kenya. PLoS Negl Trop Dis. 2014;8:e2724.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Ondigo BN, Muok EMO, Oguso JK, Njenga SM, Kanyi HM, Ndombi EM et al. Impact of mothers’ schistosomiasis status during gestation on children’s igg antibody responses to routine vaccines 2 years later and anti-schistosome and anti-malarial responses by neonates in western Kenya. Front Immunol. 2018;9.

  51. Kjetland EF, Kurewa EN, Ndhlovu PD, Midzi N, Gwanzura L, Mason PR, et al. Female genital schistosomiasis - a differential diagnosis to sexually transmitted disease: genital itch and vaginal discharge as indicators of genital Schistosoma haematobium morbidity in a cross-sectional study in endemic rural Zimbabwe. Trop Med Int Health. 2008;13:1509–17.

    Article  PubMed  Google Scholar 

  52. Rite EE, Kapalata SN, Munisi DZ. Prevalence, intensity, and factors associated with urogenital schistosomiasis among women of reproductive age in Mbogwe district council, geita region, Tanzania. BioMed Res Int. 2020;2020:5923025.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Poggensee G, Kiwelu I, Weger V, Göppner D, Diedrich T, Krantz I, et al. Female genital schistosomiasis of the lower genital tract: prevalence and disease-associated morbidity in northern Tanzania. J Infect Dis. 2000;181:1210–3.

    Article  CAS  PubMed  Google Scholar 

  54. Mitchell KB, Fitzgerald DW, Simplice H, Downs JA, Johnson WD, Bang H, et al. Urogenital schistosomiasis in women of reproductive age in Tanzania’s Lake Victoria region. Am J Trop Med Hyg. 2011;84:364–9.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Keller D, Rothen J, Dangy J-P, Saner C, Daubenberger C, Allan F, et al. Performance of a real-time PCR approach for diagnosing Schistosoma haematobium infections of different intensity in urine samples from Zanzibar. Infect Dis Poverty. 2020;9:128.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Meurs L, Mbow M, Vereecken K, Menten J, Mboup S, Polman K. Epidemiology of mixed Schistosoma mansoni and Schistosoma haematobium infections in northern Senegal. Int J Parasitol. 2012;42:305–11.

    Article  PubMed  Google Scholar 

  57. Knopp S, Ame SM, Hattendorf J, Ali SM, Khamis IS, Bakar F, et al. Urogenital schistosomiasis elimination in Zanzibar: accuracy of urine filtration and haematuria reagent strips for diagnosing light intensity Schistosoma haematobium infections. Parasit Vectors. 2018;11:552.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Savioli L, Hatz C, Dixon H, Kisumku UM, Mott KE. Control of morbidity due to Schistosoma haematobium on Pemba Island: egg excretion and hematuria as indicators of infection. Am J Trop Med Hyg. 1990;43:289–95.

    Article  CAS  PubMed  Google Scholar 

  59. Huang Y, Manderson L. Schistosomiasis and the social patterning of infection. Acta Trop. 1992;51:175–94.

    Article  CAS  PubMed  Google Scholar 

  60. Coutinho EM, Abath FG, Barbosa CS, Domingues AL, Melo MC, Montenegro SM, et al. Factors involved in Schistosoma mansoni infection in rural areas of northeast Brazil. Mem Inst Oswaldo Cruz. 1997;92:707–15.

    Article  CAS  PubMed  Google Scholar 

  61. Hajissa K, Muhajir AEMA, Eshag HA, Alfadel A, Nahied E, Dahab R, et al. Prevalence of schistosomiasis and associated risk factors among school children in Um-Asher Area, Khartoum, Sudan. BMC Res Notes. 2018;11:779.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Aikowe JO, Mazancová J. Barriers to water access in rural communities: examining the factors influencing water source choice. Water. 2021;13:2755.

    Article  CAS  Google Scholar 

  63. Dawaki S, Al-Mekhlafi HM, Ithoi I, Ibrahim J, Abdulsalam AM, Ahmed A, et al. Prevalence and risk factors of schistosomiasis among Hausa communities in Kano State, Nigeria. Rev Inst Med Trop São Paulo. 2016;58:54.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Shams M, Khazaei S, Ghasemi E, Nazari N, Javanmardi E, Majidiani H, et al. Prevalence of urinary schistosomiasis in women: a systematic review and meta-analysis of recently published literature (2016–2020). Trop Med Health. 2022;50:1–18.

    Article  Google Scholar 

  65. Friedman JF, Kanzaria HK, McGarvey ST. Human schistosomiasis and anemia: the relationship and potential mechanisms. Trends Parasitol. 2005;21:386–92.

    Article  PubMed  Google Scholar 

Download references


We would like to thank the midwives and technicians from the EPS in Richard Toll and the Senegalese sugar company’s health center. We are very grateful to the community and the population for their cooperation.


The PhD student Coumba Nar Ndiour has been supported by the EDCTP2 Program funded by the European Union under grant number CSA-NoE20203103. She has received a scholarship during the West African Network of Tuberculosis, AIDS, Malaria and Neglected Tropical Diseases 3 Project (WANETAM 3). The field work has been supported by the Program CEA-AGIR, grant project of the World Bank.

Author information

Authors and Affiliations



D.S., S.D. and O.T. designed the study. C.N.N. and S.N. realized the field survey, sample collection and performed the lab analysis. B.T.F., N.A.N., A.N.W. and O.S. participated to the database curation and data analysis. C.N.N. and B.S. written the original draft. All authors have read, reviewed and agreed to the published version of the manuscript.

Corresponding author

Correspondence to Doudou Sow.

Ethics declarations

Ethical approval and consent to participate

This study has received approval from the National Ethical Committee of Senegal (CNERS) under agreement number: 000017-MSAS/DPRS/CNERS. A written informed consent was obtained from each woman. All positive pregnant women after the first trimester at microscopic examination received a single dose of PZQ 40 mg/kg by their doctor.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing financial interests or personal relationships that could have appeared to influence the study reported in this manuscript.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ndiour, C.N., Senghor, B., Thiam, O. et al. Prevalence and associated factors of schistosomiasis among pregnant women in northern Senegal. BMC Infect Dis 24, 682 (2024).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: